These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10580027)

  • 21. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
    Henderson LM; Miglioretti DL; Kerlikowske K; Wernli KJ; Sprague BL; Lehman CD
    AJR Am J Roentgenol; 2015 Sep; 205(3):676-84. PubMed ID: 26295657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
    Musolino A; Michiara M; Conti GM; Boggiani D; Zatelli M; Palleschi D; Bella MA; Sgargi P; Di Blasio B; Ardizzoni A
    J Clin Oncol; 2012 Jul; 30(19):2362-8. PubMed ID: 22585698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
    Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
    Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
    Randall D; Morrell S; Taylor R; Hung WT
    Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study.
    Pollán M; Ascunce N; Ederra M; Murillo A; Erdozáin N; Alés-Martínez J; Pastor-Barriuso R
    Breast Cancer Res; 2013 Jan; 15(1):R9. PubMed ID: 23360535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
    Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
    Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors.
    Collett K; Stefansson IM; Eide J; Braaten A; Wang H; Eide GE; Thoresen SØ; Foulkes WD; Akslen LA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1108-12. PubMed ID: 15894660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
    Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
    Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
    JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.